目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 24)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 30)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
2.8 IMPACT OF RECESSION ON PREFILLED SYRINGES MARKET

3 EXECUTIVE SUMMARY (Page No. - 45)

4 PREMIUM INSIGHTS (Page No. - 50)
4.1 PREFILLED SYRINGES MARKET OVERVIEW
4.2 ASIA PACIFIC: PREFILLED SYRINGES MARKET OVERVIEW
4.3 PREFILLED SYRINGES MARKET: REGIONAL MIX
4.4 PREFILLED SYRINGES MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
4.5 PREFILLED SYRINGES MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW (Page No. - 55)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of chronic diseases
5.2.1.2 Growing adoption of self-injection devices
5.2.1.3 Increasing adoption of prefilled syringes in parenteral dosage forms
5.2.1.4 Increased use of biologics and vaccines
5.2.1.5 Technological advancements in prefilled syringes
5.2.2 RESTRAINTS
5.2.2.1 Stringent government regulations
5.2.2.2 Impact of product recalls
5.2.3 OPPORTUNITIES
5.2.3.1 Growing preference for unit-dose medication using prefilled syringes
5.2.3.2 Emerging markets with growing healthcare infrastructure
5.2.4 CHALLENGES
5.2.4.1 Alternative drug delivery methods
5.2.4.2 Infections associated with needlestick injuries
5.3 INDUSTRY TRENDS
5.3.1 PREFILLED BIOLOGICS
5.3.2 INTEGRATED SAFETY FEATURES
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Integration disinfection unit (IDU)
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Cyclic olefin polymers (COP) and cyclic olefin copolymers (COC)
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Integration with autoinjectors
5.5 VALUE CHAIN ANALYSIS
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY ANALYSIS
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 CASE STUDY ANALYSIS
5.8.1 CASE STUDY 1: ENVIRONMENTAL BENEFITS OF USING PREFILLED ‘EMERGENCY’ DRUGS
5.8.2 CASE STUDY 2: DEVELOPMENT OF NOVEL PHARMACEUTICAL DRUG MODALITIES REQUIRING FROZEN STORAGE AND TRANSPORTATION
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE OF PREFILLED SYRINGES, BY TYPE, 2022-2024
5.9.2 AVERAGE SELLING PRICE TREND, BY REGION, 2022-2024
5.10 UNMET NEEDS
5.11 ECOSYSTEM ANALYSIS
5.12 SUPPLY CHAIN ANALYSIS
5.13 ADJACENT MARKET ANALYSIS
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.15 TRADE ANALYSIS
5.16 PATENT ANALYSIS
5.16.1 PATENT PUBLICATION TRENDS FOR PREFILLED SYRINGES
5.16.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.16.3 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PREFILLED SYRINGE PATENTS (JANUARY 2014−APRIL 2024)
5.16.4 TOP APPLICANT COUNTRIES/REGIONS PATENTS FOR PREFILLED SYRINGES (JANUARY 2014−APRIL 2024)
5.17 KEY CONFERENCES & EVENTS DURING 2024-2025
5.18 KEY STAKEHOLDERS & BUYING CRITERIA
5.18.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.18.2 BUYING CRITERIA
5.19 INVESTMENT & FUNDING SCENARIO
5.20 REIMBURSEMENT SCENARIO
5.21 MARKET ANALYSIS OF PREFILLED SYRINGE COMPONENTS
5.21.1 PLUNGER STOPPERS

6 PREFILLED SYRINGES MARKET, BY TYPE (Page No. - 89)
6.1 INTRODUCTION
6.2 CONVENTIONAL PREFILLED SYRINGES
6.2.1 DISPOSABLE PREFILLED SYRINGES
6.2.1.1 Increasing focus on patient safety to drive market
6.2.2 REUSABLE PREFILLED SYRINGES
6.2.2.1 Cost-effectiveness and technological advancements to drive market
6.3 SAFETY PREFILLED SYRINGES
6.3.1 INTEGRATED SAFETY FEATURES TO BOOST ADOPTION

7 PREFILLED SYRINGES MARKET, BY DESIGN (Page No. - 99)
7.1 INTRODUCTION
7.2 SINGLE-CHAMBER PREFILLED SYRINGES
7.2.1 CONVENIENCE, SAFETY, AND EFFICIENCY OF SINGLE-CHAMBER SYRINGES TO SUPPORT MARKET GROWTH
7.3 DUAL-CHAMBER PREFILLED SYRINGES
7.3.1 UNIQUE ADVANTAGES AND SPECIFIC APPLICATIONS OF DUAL-CHAMBER SYRINGES TO DRIVE DEMAND
7.4 CUSTOMIZED PREFILLED SYRINGES
7.4.1 PATIENT-FRIENDLY FEATURES SUCH AS EASY-TO-READ DOSAGE INDICATORS AND SAFETY MECHANISMS TO BOOST ADOPTION

8 PREFILLED SYRINGES MARKET, BY MATERIAL (Page No. - 106)
8.1 INTRODUCTION
8.2 GLASS PREFILLED SYRINGES
8.2.1 ABILITY OF GLASS PREFILLED SYRINGES TO OFFER SUPERIOR BARRIER PROPERTIES TO BOOST MARKET GROWTH
8.3 PLASTIC PREFILLED SYRINGES
8.3.1 IMPROVED SAFETY, COST-EFFECTIVENESS, VERSATILITY, AND CONVENIENCE OF PLASTIC SYRINGES TO SUPPORT ADOPTION

9 PREFILLED SYRINGES MARKET, BY APPLICATION (Page No. - 111)
9.1 INTRODUCTION
9.2 DIABETES
9.2.1 INCREASING PREVALENCE OF DIABETES TO FAVOR MARKET GROWTH
9.3 RHEUMATOID ARTHRITIS
9.3.1 RISING DEMAND FOR EFFECTIVE AND CONVENIENT TREATMENT OPTIONS FOR RHEUMATOID ARTHRITIS TO DRIVE MARKET
9.4 ANAPHYLAXIS
9.4.1 CONVENIENCE OF PREFILLED SYRINGES TO ADMINISTER MEDICATION QUICKLY DURING ANAPHYLACTIC EPISODES TO BOOST GROWTH
9.5 CANCER
9.5.1 RISING GLOBAL CANCER RATES TO SUPPORT MARKET GROWTH
9.6 THROMBOSIS
9.6.1 MINIMIZED RISK OF CONTAMINATION AND INFECTION ASSOCIATED WITH PREFILLED SYRINGES TO DRIVE DEMAND
9.7 OPHTHALMOLOGY
9.7.1 FEWER SIDE-EFFECTS ASSOCIATED WITH PREFILLED SYRINGES COMPARED TO TOPICAL MEDICATIONS TO SUPPORT GROWTH
9.8 OTHER APPLICATIONS

10 PREFILLED SYRINGES MARKET, BY REGION (Page No. - 123)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: RECESSION IMPACT
10.2.2 US
10.2.2.1 US to dominate North American prefilled syringes market
10.2.3 CANADA
10.2.3.1 Increasing government support and rising incidence of chronic diseases to drive market
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Germany to dominate market in Europe
10.3.3 UK
10.3.3.1 Growing number of CVD and diabetes patients to drive market growth
10.3.4 FRANCE
10.3.4.1 Increasing needlestick injuries and growing trend of self-administration to drive market growth
10.3.5 SPAIN
10.3.5.1 Increase in biologics production to support market growth
10.3.6 ITALY
10.3.6.1 Growing focus of pharmaceutical and medical device companies to boost market growth
10.3.7 REST OF EUROPE (ROE)
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: RECESSION IMPACT
10.4.2 JAPAN
10.4.2.1 Increased geriatric population and favorable government initiatives to drive market growth in Japan
10.4.3 CHINA
10.4.3.1 Rising prevalence of chronic diseases to augment market growth
10.4.4 INDIA
10.4.4.1 High incidence of cancer and increased adoption of biosimilars to fuel market growth
10.4.5 AUSTRALIA
10.4.5.1 Growing healthcare expenditure to aid market growth
10.4.6 SOUTH KOREA
10.4.6.1 Well-developed healthcare sector and presence of major pharmaceutical manufacturers to drive market
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: RECESSION IMPACT
10.5.2 BRAZIL
10.5.2.1 Rising incidence of chronic diseases and increasing obesity to augment market growth
10.5.3 MEXICO
10.5.3.1 Increasing focus of government on healthcare and growing medical tourism to propel market
10.5.4 ARGENTINA
10.5.4.1 Increasing focus of government on healthcare and growing medical tourism to propel market
10.5.5 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING PUBLIC HEALTHCARE SPENDING TO BOOST MARKET
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
10.7 GCC COUNTRIES
10.7.1 INCREASING HEALTHCARE EXPENDITURE TO DRIVE MARKET
10.7.2 GCC COUNTRIES: RECESSION IMPACT

11 COMPETITIVE LANDSCAPE (Page No. - 200)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PREFILLED SYRINGES MARKET
11.3 REVENUE ANALYSIS
11.4 MARKET SHARE ANALYSIS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Type footprint
11.5.5.3 Material footprint
11.5.5.4 Design footprint
11.5.5.5 Application footprint
11.5.5.6 Region footprint
11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
11.7 BRAND/PRODUCT COMPARISON
11.7.1 BD
11.7.2 GERRESHEIMER AG
11.7.3 STEVANATO GROUP
11.7.4 SCHOTT GROUP
11.7.5 NIPRO
11.8 R&D EXPENDITURE
11.9 COMPETITIVE SITUATION
11.9.1 PRODUCT LAUNCHES
11.9.2 DEALS
11.9.3 EXPANSIONS
11.10 COMPANY VALUATION & FINANCIAL METRICS

12 COMPANY PROFILES (Page No. - 229)
12.1 KEY PLAYERS
12.1.1 BD
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Product launches & approvals
12.1.1.3.2 Deals
12.1.1.3.3 Expansions
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 GERRESHEIMER AG
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Deals
12.1.2.3.2 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 SCHOTT
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Expansions
12.1.3.4 MnM view
12.1.3.4.1 Right to win
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 WEST PHARMACEUTICAL SERVICES, INC.
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Deals
12.1.4.3.2 Expansions
12.1.5 APTARGROUP, INC.
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Deals
12.1.5.3.2 Expansions
12.1.6 NIPRO
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.7 BAXTER (SIMTRA)
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.7.3.2 Expansions
12.1.8 OWEN MUMFORD LTD.
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Product launches
12.1.8.3.2 Deals
12.1.9 WEIGAO MEDICAL INTERNATIONAL CO., LTD
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.10 CREDENCE MEDSYSTEMS, INC.
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.11 NOVARTIS AG
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.12 STEVANATO GROUP
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.12.3 Recent developments
12.1.12.3.1 Product launches
12.1.12.3.2 Deals
12.1.12.3.3 Expansions
12.1.13 POLYMEDICURE
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.14 MEDXL INC.
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.15 SHARPS TECHNOLOGY, INC.
12.1.15.1 Business overview
12.1.15.2 Products offered
12.2 OTHER PLAYERS
12.2.1 FRESENIUS KABI USA
12.2.2 MEDEFIL, INC.
12.2.3 D.B.M. S.R.L.
12.2.4 TAISEI KAKO CO., LTD.
12.2.5 SHANDONG PROVINCE MEDICINAL GLASS CO., LTD.
12.2.6 SHIN YAN SHENO PRECISION INDUSTRIAL CO., LTD.
12.2.7 J.O. PHARMA CO., LTD. (OTSUKA HOLDINGS CO., LTD.)
12.2.8 BMI KOREA
12.2.9 B. BRAUN SE
12.2.10 AL SHIFA MEDICAL PRODUCTS CO.

13 APPENDIX (Page No. - 284)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS

LIST OF TABLES (243 TABLES)
TABLE 1 STANDARD CURRENCY CONVERSION RATES
TABLE 2 RISK ASSESSMENT: PREFILLED SYRINGES MARKET
TABLE 3 PREFILLED SYRINGES MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 AVERAGE SELLING PRICE OF PREFILLED SYRINGES, BY TYPE, 2022-2024 (USD)
TABLE 10 AVERAGE SELLING PRICE OF CONVENTIONAL PREFILLED SYRINGES, BY REGION, 2022-2024 (USD)
TABLE 11 AVERAGE SELLING PRICE OF SAFETY PREFILLED SYRINGES, BY REGION, 2022-2024 (USD)
TABLE 12 PREFILLED SYRINGES MARKET: ECOSYSTEM ANALYSIS
TABLE 13 IMPORT DATA FOR PREFILLED SYRINGES (HS CODE 90183100), BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 14 EXPORT DATA FOR PREFILLED SYRINGES (HS CODE 90183100), BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 15 LIST OF PATENTS IN PREFILLED SYRINGES MARKET (2022−2024)
TABLE 16 PREFILLED SYRINGES MARKET: KEY CONFERENCES & EVENTS (2024-2025)
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PREFILLED SYRINGES
TABLE 18 KEY BUYING CRITERIA FOR PREFILLED SYRINGES
TABLE 19 PRODUCT ANALYSIS OF KEY PLAYERS IN PREFILLED SYRINGE COMPONENTS
TABLE 20 PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 21 CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 22 CONVENTIONAL PREFILLED SYRINGES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 23 CONVENTIONAL PREFILLED SYRINGES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 24 DISPOSABLE PREFILLED SYRINGES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 25 DISPOSABLE PREFILLED SYRINGES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 26 REUSABLE PREFILLED SYRINGES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 27 REUSABLE PREFILLED SYRINGES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 28 SAFETY PREFILLED SYRINGES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
TABLE 29 SAFETY PREFILLED SYRINGES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 30 PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 31 SINGLE-CHAMBER PREFILLED SYRINGES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 32 DUAL-CHAMBER PREFILLED SYRINGES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 33 CUSTOMIZED PREFILLED SYRINGES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 34 PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 35 GLASS PREFILLED SYRINGES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 36 PLASTIC PREFILLED SYRINGES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 37 PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 38 PREFILLED SYRINGES MARKET FOR DIABETES APPLICATIONS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 39 PREFILLED SYRINGES MARKET FOR RHEUMATOID ARTHRITIS APPLICATIONS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 40 PREFILLED SYRINGES MARKET FOR ANAPHYLAXIS APPLICATIONS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 41 PREFILLED SYRINGES MARKET FOR CANCER APPLICATIONS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 42 PREFILLED SYRINGES MARKET FOR THROMBOSIS APPLICATIONS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 43 PREFILLED SYRINGES MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 44 PREFILLED SYRINGES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 45 PREFILLED SYRINGES MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 46 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 47 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 48 NORTH AMERICA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 49 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 50 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 51 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 52 US: KEY MACROINDICATORS
TABLE 53 US: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 54 US: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 55 US: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 56 US: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 57 US: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 58 CANADA: KEY MACROINDICATORS
TABLE 59 CANADA: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 60 CANADA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 61 CANADA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 62 CANADA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 63 CANADA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 64 EUROPE: PREFILLED SYRINGES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 65 EUROPE: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 66 EUROPE: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 67 EUROPE: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 68 EUROPE: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 69 EUROPE: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 70 GERMANY: KEY MACROINDICATORS
TABLE 71 GERMANY: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 72 GERMANY: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 73 GERMANY: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 74 GERMANY: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 75 GERMANY: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 76 UK: KEY MACROINDICATORS
TABLE 77 UK: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 78 UK: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 79 UK: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 80 UK: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 81 UK: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 82 FRANCE: KEY MACROINDICATORS
TABLE 83 FRANCE: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 84 FRANCE: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 85 FRANCE: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 86 FRANCE: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 87 FRANCE: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 88 SPAIN: KEY MACROINDICATORS
TABLE 89 SPAIN: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 90 SPAIN: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 91 SPAIN: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 92 SPAIN: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 93 SPAIN: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 94 ITALY: KEY MACROINDICATORS
TABLE 95 ITALY: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 96 ITALY: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 97 ITALY: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 98 ITALY: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 99 ITALY: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 100 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 101 REST OF EUROPE: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 102 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 103 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 104 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 105 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 106 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 107 ASIA PACIFIC: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 108 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 109 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 110 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 111 JAPAN: KEY MACROINDICATORS
TABLE 112 JAPAN: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 113 JAPAN: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 114 JAPAN: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 115 JAPAN: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 116 JAPAN: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 117 CHINA: KEY MACROINDICATORS
TABLE 118 CHINA: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 119 CHINA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 120 CHINA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 121 CHINA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 122 CHINA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 123 INDIA: KEY MACROINDICATORS
TABLE 124 INDIA: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 125 INDIA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 126 INDIA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 127 INDIA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 128 INDIA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 129 AUSTRALIA: KEY MACROINDICATORS
TABLE 130 AUSTRALIA: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 131 AUSTRALIA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 132 AUSTRALIA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 133 AUSTRALIA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 134 AUSTRALIA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 135 SOUTH KOREA: KEY MACROINDICATORS
TABLE 136 SOUTH KOREA: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 137 SOUTH KOREA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 138 SOUTH KOREA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 139 SOUTH KOREA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 140 SOUTH KOREA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 141 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 142 REST OF ASIA PACIFIC: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 143 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 144 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 145 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 146 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 147 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 148 LATIN AMERICA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 149 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 150 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 151 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 152 BRAZIL: KEY MACROINDICATORS
TABLE 153 BRAZIL: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 154 BRAZIL: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 155 BRAZIL: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 156 BRAZIL: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 157 BRAZIL: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 158 MEXICO: KEY MACROINDICATORS
TABLE 159 MEXICO: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 160 MEXICO: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 161 MEXICO: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 162 MEXICO: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 163 MEXICO: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 164 ARGENTINA: KEY MACROINDICATORS
TABLE 165 ARGENTINA: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 166 ARGENTINA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 167 ARGENTINA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 168 ARGENTINA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 169 ARGENTINA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 170 REST OF LATIN AMERICA: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 171 REST OF LATIN AMERICA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 172 REST OF LATIN AMERICA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 173 REST OF LATIN AMERICA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 174 REST OF LATIN AMERICA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 175 MIDDLE EAST & AFRICA: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 176 MIDDLE EAST & AFRICA: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 177 MIDDLE EAST & AFRICA: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 180 GCC COUNTRIES: PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 181 GCC COUNTRIES: CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 182 GCC COUNTRIES: PREFILLED SYRINGES MARKET, BY MATERIAL, 2022-2030 (USD MILLION)
TABLE 183 GCC COUNTRIES: PREFILLED SYRINGES MARKET, BY DESIGN, 2022-2030 (USD MILLION)
TABLE 184 GCC COUNTRIES: PREFILLED SYRINGES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 185 PREFILLED SYRINGES MARKET: DEGREE OF COMPETITION
TABLE 186 PREFILLED SYRINGES MARKET: TYPE FOOTPRINT
TABLE 187 PREFILLED SYRINGES MARKET: MATERIAL FOOTPRINT
TABLE 188 PREFILLED SYRINGES MARKET: DESIGN FOOTPRINT
TABLE 189 PREFILLED SYRINGES MARKET: APPLICATION FOOTPRINT
TABLE 190 PREFILLED SYRINGES MARKET: REGION FOOTPRINT
TABLE 191 PREFILLED SYRINGES MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 192 PREFILLED SYRINGES MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS
TABLE 193 PREFILLED SYRINGES MARKET: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2024
TABLE 194 PREFILLED SYRINGES MARKET: DEALS, JANUARY 2021-JUNE 2024
TABLE 195 PREFILLED SYRINGES MARKET: EXPANSIONS, JANUARY 2021-JUNE 2024
TABLE 196 BD: COMPANY OVERVIEW
TABLE 197 BD: PRODUCTS OFFERED
TABLE 198 BD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JUNE 2024
TABLE 199 BD: DEALS, JANUARY 2021-JUNE 2024
TABLE 200 BD: EXPANSIONS, JANUARY 2021-JUNE 2024
TABLE 201 GERRESHEIMER AG: COMPANY OVERVIEW
TABLE 202 GERRESHEIMER AG: PRODUCTS OFFERED
TABLE 203 GERRESHEIMER AG: DEALS, JANUARY 2021-JUNE 2024
TABLE 204 GERRESHEIMER AG: EXPANSIONS, JANUARY 2021-JUNE 2024
TABLE 205 SCHOTT: COMPANY OVERVIEW
TABLE 206 SCHOTT: PRODUCTS OFFERED
TABLE 207 SCHOTT: EXPANSIONS, JANUARY 2021-JUNE 2024
TABLE 208 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW
TABLE 209 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS OFFERED
TABLE 210 WEST PHARMACEUTICAL SERVICES, INC.: DEALS, JANUARY 2021-JUNE 2024
TABLE 211 WEST PHARMACEUTICAL SERVICES, INC.: EXPANSIONS, JANUARY 2021-JUNE 2024
TABLE 212 APTARGROUP, INC.: COMPANY OVERVIEW
TABLE 213 APTARGROUP, INC.: PRODUCTS OFFERED
TABLE 214 APTARGROUP, INC.: DEALS, JANUARY 2021-JUNE 2024
TABLE 215 APTARGROUP, INC.: EXPANSIONS, JANUARY 2021-JUNE 2024
TABLE 216 NIPRO: COMPANY OVERVIEW
TABLE 217 NIPRO: PRODUCTS OFFERED
TABLE 218 BAXTER (SIMTRA): COMPANY OVERVIEW
TABLE 219 BAXTER (SIMTRA): PRODUCTS OFFERED
TABLE 220 BAXTER (SIMTRA): DEALS, JANUARY 2021-JUNE 2024
TABLE 221 BAXTER (SIMTRA): EXPANSIONS, JANUARY 2021-JUNE 2024
TABLE 222 OWEN MUMFORD LTD.: COMPANY OVERVIEW
TABLE 223 OWEN MUMFORD LTD.: PRODUCTS OFFERED
TABLE 224 OWEN MUMFORD LTD.: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2024
TABLE 225 OWEN MUMFORD LTD.: DEALS, JANUARY 2021-JUNE 2024
TABLE 226 WEIGAO MEDICAL INTERNATIONAL CO., LTD.: COMPANY OVERVIEW
TABLE 227 WEIGAO MEDICAL INTERNATIONAL CO., LTD.: PRODUCTS OFFERED
TABLE 228 CREDENCE MEDSYSTEMS, INC.: COMPANY OVERVIEW
TABLE 229 CREDENCE MEDSYSTEMS, INC.: PRODUCTS OFFERED
TABLE 230 NOVARTIS AG: COMPANY OVERVIEW
TABLE 231 NOVARTIS AG: PRODUCTS OFFERED
TABLE 232 NOVARTIS AG: DEALS, JANUARY 2021-JUNE 2024
TABLE 233 STEVANATO GROUP: COMPANY OVERVIEW
TABLE 234 STEVANATO GROUP: PRODUCTS OFFERED
TABLE 235 STEVANATO GROUP: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2024
TABLE 236 STEVANATO GROUP: DEALS, JANUARY 2021-MARCH 2024
TABLE 237 STEVANATO GROUP: EXPANSIONS, JANUARY 2021-JUNE 2024
TABLE 238 POLYMEDICURE: COMPANY OVERVIEW
TABLE 239 POLYMEDICURE: PRODUCTS OFFERED
TABLE 240 MEDXL INC.: COMPANY OVERVIEW
TABLE 241 MEDXL INC.: PRODUCTS OFFERED
TABLE 242 SHARPS TECHNOLOGY, INC.: COMPANY OVERVIEW
TABLE 243 SHARPS TECHNOLOGY, INC.: PRODUCTS OFFERED

LIST OF FIGURES (59 FIGURES)
FIGURE 1 PREFILLED SYRINGES MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: BD (2023)
FIGURE 9 PREFILLED SYRINGES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION (2023)
FIGURE 10 PREFILLED SYRINGES MARKET: TOP-DOWN APPROACH
FIGURE 11 CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS (2024-2030)
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 13 DATA TRIANGULATION METHODOLOGY
FIGURE 14 PREFILLED SYRINGES MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION)
FIGURE 15 CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION)
FIGURE 16 PREFILLED SYRINGES MARKET, BY MATERIAL, 2024 VS. 2030 (USD MILLION)
FIGURE 17 PREFILLED SYRINGES MARKET, BY DESIGN, 2024 VS. 2030 (USD MILLION)
FIGURE 18 PREFILLED SYRINGES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
FIGURE 19 GEOGRAPHIC SNAPSHOT OF PREFILLED SYRINGES MARKET
FIGURE 20 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE GROWTH IN PREFILLED SYRINGES MARKET
FIGURE 21 CONVENTIONAL PREFILLED SYRINGES ACCOUNTED FOR LARGEST SHARE OF APAC PREFILLED SYRINGES MARKET IN 2023
FIGURE 22 NORTH AMERICA TO DOMINATE MARKET THROUGHOUT FORECAST PERIOD
FIGURE 23 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 24 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 25 PREFILLED SYRINGES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 26 PREFILLED SYRINGES MARKET: VALUE CHAIN ANALYSIS
FIGURE 27 PREFILLED SYRINGES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 28 PREFILLED SYRINGES MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 29 ADJACENT MARKETS TO PREFILLED SYRINGES MARKET
FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN PREFILLED SYRINGES MARKET
FIGURE 31 GLOBAL PATENT PUBLICATION TRENDS (JANUARY 2014-JUNE 2024)
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PREFILLED SYRINGES
FIGURE 33 KEY BUYING CRITERIA FOR PREFILLED SYRINGES, BY TYPE
FIGURE 34 INVESTMENT/VENTURE CAPITAL SCENARIO IN PREFILLED SYRINGES MARKET, 2021-2024
FIGURE 35 PREFILLED SYRINGES MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 36 NORTH AMERICA: PREFILLED SYRINGES MARKET SNAPSHOT
FIGURE 37 EUROPE: PREFILLED SYRINGES MARKET SNAPSHOT
FIGURE 38 ASIA PACIFIC: PREFILLED SYRINGES MARKET SNAPSHOT
FIGURE 39 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES
FIGURE 40 PREFILLED SYRINGES MARKET: REVENUE ANALYSIS, 2019-2023
FIGURE 41 PREFILLED SYRINGES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2023
FIGURE 42 PREFILLED SYRINGES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 43 PREFILLED SYRINGES MARKET: COMPANY FOOTPRINT
FIGURE 44 PREFILLED SYRINGES MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
FIGURE 45 PREFILLED SYRINGES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 46 R&D EXPENDITURE OF KEY PLAYERS, 2022 VS. 2023
FIGURE 47 EV/EBITDA OF KEY VENDORS
FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 49 BD: COMPANY SNAPSHOT (2023)
FIGURE 50 GERRESHEIMER AG: COMPANY SNAPSHOT (2023)
FIGURE 51 SCHOTT: COMPANY SNAPSHOT (2023)
FIGURE 52 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 53 APTARGROUP, INC.: COMPANY SNAPSHOT (2023)
FIGURE 54 NIPRO: COMPANY SNAPSHOT (2023)
FIGURE 55 BAXTER (SIMTRA): COMPANY SNAPSHOT (2023)
FIGURE 56 WEIGAO MEDICAL INTERNATIONAL CO., LTD.: COMPANY SNAPSHOT (2023)
FIGURE 57 NOVARTIS AG: COMPANY SNAPSHOT (2023)
FIGURE 58 STEVANATO GROUP: COMPANY SNAPSHOT (2023)
FIGURE 59 POLYMEDICURE: COMPANY SNAPSHOT (2023)